Pharmaceuticals

Transfection Technologies Market Developments Shaping Growth Across The Forecast Period

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Transfection Technologies Market During 2026–2030?

The transfection technologies market has witnessed significant growth in its size over recent years. It is projected to expand from $1.31 billion in 2025 to $1.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical growth can be attributed to the rise in molecular biology research, advancements in gene expression studies, the increasing needs for protein production, augmented funding for genomics research, and its initial adoption within academic laboratories.

The transfection technologies market is projected to experience robust expansion over the coming years. Its valuation is set to reach $1.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the proliferation of cell and gene therapies, the expanding pipelines for RNA therapeutics, an uptick in life sciences research investment, the demand for efficient transfection reagents, and the broadening scope of personalized medicine. Key trends anticipated for this period encompass a rising demand for gene editing research tools, the expansion of RNA-based therapeutics development, increasing use in cell and gene therapy, growth in academic and biomedical research, and the advancement in non-viral transfection methods.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Key Drivers Are Affecting The Transfection Technologies Market Development?

The increasing adoption of gene therapy is anticipated to fuel expansion within the transfection technologies market in the future. Gene therapy involves a method designed to address or avert illnesses through genetic modification, encompassing the introduction, correction, or substitution of defective genes. The growth of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capacity to manage genetic ailments that were once untreatable. Transfection technologies play a vital role in gene therapy, enabling the accurate, secure, and efficient transfer of genetic substances into cells. These technologies facilitate both transient and lasting alterations to the genome, which are indispensable for addressing genetic diseases and cancers. As an illustration, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) cleared six gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expansion of gene therapy is propelling the development of the transfection technologies market.

Which Segment Categories Are Included In The Transfection Technologies Market Segment Analysis?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Which Trends Are Shaping The Transfection Technologies Market?

Leading firms within the transfection technologies sector are concentrating on creating sophisticated technology, such as mechanoporation transfection systems, to facilitate more intricate and customized uses in research and therapeutic contexts. These mechanoporation systems utilize mechanical forces to form transient openings in cell membranes, which permits genetic material to penetrate cells. This approach is both effective and causes minimal disruption, thereby maintaining superior cell viability. As an illustration, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, introduced CellPore, an inventive transfection system. The system comprises a benchtop device and the CellPore Transfection Kit 300, supplied with a specialized reagent set and disposable delivery cartridges. By employing controlled, swift deformation within microfluidic channels, CellPore proficiently delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing low cell disturbance and robust viability. Such characteristics are vital for progressing research and the advancement of state-of-the-art cell and gene therapies.

Who Are The Active Companies Shaping The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Get The Full Transfection Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Where Is The Transfection Technologies Market Primarily Concentrated By Region?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Transfection Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795